Aplastic Anemia with Epstein-Barr Virus Reactivation after Anti-thymocyte Globulin Therapy

Intern Med. 2023 Sep 1;62(17):2553-2557. doi: 10.2169/internalmedicine.0539-22. Epub 2023 Feb 1.

Abstract

Lymphoproliferative disorders and Epstein-Barr virus reactivation (EBV-LPDs) have various forms of onset, ranging from infectious mononucleosis-like syndrome (IM-like) to lymphoma, although whether or not IM-like progresses to lymphoma remains unclear. A 61-year-old man was diagnosed with aplastic anemia (AA). Polyclonal atypical B-lymphocytes were observed in the peripheral blood, and IM-like was diagnosed. Atypical lymphocytes disappeared, but a gastrointestinal examination revealed diffuse large B-cell lymphoma (DLBCL). Rituximab was initiated but later discontinued because of severe acute respiratory syndrome coronavirus 2 infection. Pancytopenia due to AA exacerbation recurred. The patient ultimately died of multiple organ failure due to bacterial infection.

Keywords: Epstein-Barr virus; anti-thymocyte globulin; aplastic anemia; infectious mononucleosis-like syndrome; lymphoproliferative disorders.

Publication types

  • Case Reports

MeSH terms

  • Anemia, Aplastic* / complications
  • Anemia, Aplastic* / drug therapy
  • Antilymphocyte Serum / adverse effects
  • COVID-19* / complications
  • Epstein-Barr Virus Infections* / diagnosis
  • Herpesvirus 4, Human
  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / complications
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / complications

Substances

  • Antilymphocyte Serum